Procter & Gamble Co (PG) Quote | Morningstar

Skip to Content

Company Profile

Business Description

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating nearly $70 billion in annual sales. It operates with a lineup of leading brands, including 21 that generate more than $1 billion in annual global sales such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. P&G sold its last remaining food brand, Pringles, to Kellogg in calendar 2012. Sales outside its home turf represent around 55% of the firm's consolidated total, with around one third coming from emerging markets.

Contact

One Procter & Gamble Plaza
Cincinnati, OH, 45202

T +1 513 983-1100

www.pginvestor.com

Sector Consumer Defensive

Industry Household & Personal Products

Most Recent Earnings Mar 31, 2020

Fiscal Year End Jun 30, 2020

Stock Type High Yield

Employees 97,000

Related

Growth Parties Like It's 1999, but Don't Rule Out Value

Morningstar style indexes reveal market divergence and opportunity.

This Vanguard Dividend Fund Still Solid Despite Downgrade

Silver-rated Vanguard Dividend Appreciation provides investors with a diversified portfolio of highly profitable U.S. dividend-paying stocks.

Venkata Sai Uppaluri

Stock Analyst Update

P&G Weathers COVID-19, but a Storm Still Lies Ahead

We don't expect to alter our fair value estimate or long-term outlook for the wide-moat firm, but we think investors should await a more attractive risk/return opportunity.

16 Solid Stocks During Rocky Times

This shortlist of high-quality companies with predictable cash flows and modest leverage are well-equipped for today’s market uncertainty.

Susan Dziubinski

2019: A Strong Year for Income Assets, Less So for Some Income Funds

A volatile end to 2018 resulted in an overly conservative positioning going into 2019.

Fund Ideas for the New Decade

Value funds plus big upgrades are worth a look.

Stock Strategist

Although Its Upward Sales Trajectory Persists, Procter & Gamble's Shares Fail to Offer a Bargain

We are maintaining our $106 FVE.

Stock Analyst Update

Upward Sales, but Procter & Gamble Shares No Bargain

We believe investors should await a more favorable entry point before buying shares of this wide-moat firm.

The Week Ahead: Abbott Laboratories and Johnson & Johnson Due

Fourth-quarter earnings announcements from financial, consumer products, and technology sectors.

Charlotte Frank

Rekenthaler Report

The Strange and Happy Tale of Voya Corporate Leaders Trust

A fund that shouldn’t succeed, but does.

John Rekenthaler

This Quality Dividend-Growth ETF Looks to the Future

This strategy effectively targets firms that should have the capacity to raise their dividends in the future.

Stock Analyst Update

Tide Has Turned on P&G's Sales Course, Shares Pricey

Wide-moat Procter & Gamble chalked up another quarter of strong sales and profit gains.

Despite Its Valuation, This Defensive Equity ETF Is Compelling

Concerns over the valuations of this fund's holdings are overblown.

Stock Analyst Update

P&G Looks Expensive

We like what we're seeing from the wide-moat firm but think it's overvalued.

3 Unrated Large-Cap Dividend ETFs for Your Radar

The menu of dividend ETFs features something for every palate.

4 New Ideas From the Wide-Moat Focus Index

Plus, the 10 cheapest names in the index today.

Susan Dziubinski

First-Quarter Trends in 14 Charts

A visual take on the term.

Investing Specialists

Our Ultimate Stock-Picker's Top 10 Dividend-Yielding Stocks

Seven of the top 10 dividend-yielding names are undervalued.

The Morningstar Ultimate Stock-Pickers Team

A Downside Litmus Test for Funds

How did funds hold up in a nasty quarter?

Premium Article

13 Stocks to Buy on a Dip

These wide-moat, low uncertainty names may be slightly overpriced today, but they should be on quality seekers’ watchlists.

Susan Dziubinski